Evidence map›Paper›PMID 34178553›Full record

ReviewCureus2021

The New Kid on the Block: The Mechanisms of Action of Hyperleptinemia in Coronary Artery Disease and Atherosclerosis.

Vernicia Hernandez, Kavaljeet Kaur, Mohamed W ElSharief, Sari W Al Hajaj, Ahmed M Ebrahim, Mirash Razack, David Dragas

Open access · diamondAbstract readReview
In one paragraph

Review in Cureus, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Vernicia HernandezInternal Medicine, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.
Kavaljeet KaurInternal Medicine, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.
Mohamed W ElShariefPediatrics and Child Health, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.
Sari W Al HajajSurgery, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.
Ahmed M EbrahimSurgery, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.
Mirash RazackEmergency Medicine, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.
David DragasResearch, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.
California Institute of Behavioral Neurosciences and Psychology (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Leptin is an adipocytokine that consists of 167 amino acids. It functions as a regulator of hunger and energy expenditure. Leptin loses its ability to carry out its physiological function at high serum levels, and many studies have associated this loss of function with the development of coronary artery disease (CAD). This literature review aims to outline the steps by which leptin leads to CAD and atherosclerosis. Two independent researchers extracted animal and human studies from PubMed and Google Scholar databases. We applied PubMed search builder options: pathology, pathophysiology, metabolism, and physiology to focus the search results. This study concluded that the mechanism by which leptin might lead to CAD via pressor and depressor effects on vascular tone, enhancing atherosclerotic plaques, and through numerous single nucleotide polymorphisms, the most common being that of the leptin receptor gene rs113701.

Indexed as

atherosclerosiscoronary artery diseasehypertensionleptinmyocardial infarctionobesity

Identifiers

PMID34178553
PMCPMC8216571
OpenAlexW3176122532

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.